Addressing Valvular Heart Disease in Saudi Arabia

By Danélia Botes

July 11, 2024

Introduction

Valvular heart disease (VHD) poses a significant health threat to Saudi Arabia’s ageing population. Aortic stenosis, the most common form of VHD, is particularly prevalent among those over 60. Approximately 20,000 people over the age of 65 are estimated to live with symptoms of severe aortic stenosis in Saudi Arabia. Despite available treatments, many patients remain undiagnosed and untreated. Failing to address VHD results in severe and costly challenges. The impact of VHD is projected to increase in Saudi’s ageing population.

Understanding Valvular Heart Disease in Saudi Arabia

Valvular heart disease significantly impacts older adults, with aortic stenosis being the most common form. Risk factors include age, smoking, hypertension, and elevated cholesterol levels. There is a high mortality rate for these patients within two years if severe symptomatic aortic stenosis remains untreated. In Saudi Arabia, 2-7% of people over 60 are estimated to have aortic stenosis. However, diagnosis rates are alarmingly low, leading to severe health complications and increased healthcare costs.

Barriers to Optimal Care

Several barriers prevent effective VHD care in Saudi Arabia. These include:

  • Lack of Awareness: Both the public and healthcare professionals (HCPs) often misattribute VHD symptoms to natural ageing.
  • Inadequate Training: Primary care physicians (PCPs) may not be equipped to detect VHD through simple auscultation.
  • Limited Research: Insufficient local data on VHD prevalence hampers effective policy-making and resource allocation.
Figure 1. The main reasons for underdiagnosis of severe aortic stenosis
are connected with PCPs

Actions for Policy-Makers

Policy-makers play a crucial role in addressing these barriers. The need to prioritise raising public awareness about VHD symptoms and encouraging regular check-ups. Implementing dedicated screening programs as part of healthy ageing initiatives should also be encouraged by policymakers. They also need to be responsible for ensuring well-trained interventional cardiologists and cardiac surgeons are available for treating VHD patients.

Actions for Health Systems and HCPs

Healthcare systems and professionals must also take proactive steps. They need to ensure adequate training of PCPs to effectively examine and detect VHD, specifically aortic stenosis. Physicians need to be encouraging routine screening for VHD in primary care for those over 60. This will assist with reducing the numbers of undetected aortic stenosis in the Saudi population. Establishing clear referral pathways for patients diagnosed with VHD is crucial to ensure timely care by the specialists and physicians.

Priority Areas for Research

Research is another essential aspect to inform health policies and improve VHD care. Priority areas include gathering data on the epidemiology of VHD in Saudi Arabia. There is currently a global under-reporting of VHDs which leads to lack of public recognition and insufficient prioritisation within healthcare. Funding local studies on VHD will not only assist with local treatment guidelines but also to guide health policy development. We can also use local research to evaluate the outcomes of strategies that intervene in VHD.

Improving Disease Management

Effective disease management requires a coordinated approach. Each health system level needs a well-defined workforce plan to guarantee the availability of necessary skills and resources. Leveraging digital platforms for regular patient follow-ups and improved care coordination will enable accelerated access to care. Implementing integrated, multidisciplinary care teams to provide comprehensive VHD care will ensure well rounded care.

Conclusion

Addressing valvular heart disease in Saudi Arabia is essential for improving the health of the ageing population. A five-fold increase in aortic stenosis is expected by 2050 in Saudi Arabia. By raising awareness, enhancing detection, and providing timely treatment, we can mitigate the impact of VHD. This aligns with Saudi Vision 2030’s goal of creating a healthier society. Investing in better VHD care will save costs in the long run and improve the quality of life for many older adults.

 

Reference url

Recent Posts

AI Drug Safety Surveillance
           

Created and Validated by FDA: AI Drug Safety Surveillance Tool

🚀 Discover how the AI-driven LabelComp tool is transforming drug safety surveillance! By automating the identification of adverse events in drug labelling, LabelComp enhances accuracy and efficiency, supporting regulatory decision-making and public health. 🌐💊
#SyenzaNews #AIinHealthcare #DrugSafety #PharmaInnovation #RegulatoryScience

School-based health centres
                      

The Role of School-Based Health Centres in Advancing Health Equity

🌟 School-based health centres (SBHCs) are improving healthcare for underserved youth across the US! These centres provide vital services, from preventive care to chronic disease management, right where students need them most – in schools. 📚🏥

SBHCs improve academic performance, reduce absenteeism, and enhance overall student well-being. Let’s support these essential centres and ensure every child has access to quality healthcare. 🌟

#SyenzaNews #SBHC #ChronicDiseaseManagement #HealthEquity #PreventiveCare

ABA guidelines for Autism
                

Enhancing Care in Abu Dhabi: The New ABA Guidelines for Autism

🌟 Exciting developments in Abu Dhabi! The Department of Health has introduced new ABA guidelines for Autism Spectrum Disorder, aiming to improve care for People of Determination. This initiative focuses on standardising care, enhancing accessibility, and fostering collaboration between healthcare and education professionals.
Learn more about how these guidelines can make a difference in the lives of individuals with ASD.
#SyenzaNews #HealthcareInnovation #AutismCare #InclusiveHealth #ABAGuidelines #AbuDhabiHealth

When you collaborate with VSH Foundation, it's like unlocking a new dimension in healthcare innovation.

Our research synergizes with your vision, combining expertise in health economics, policy analysis, advanced analytics, and AI applications in healthcare. You’ll witness the fusion of cutting-edge methodologies and real- world impact, as we work together to transform healthcare systems and improve patient outcomes globally.

CORRESPONDENCE ADDRESS

PO Box 8547, #95478, Boston, MA 02114, USA

© 2024 Value Science Health Foundation. All rights reserved.
Made with by Frogiez